Targeting HER2-AXL heterodimerization to overcome resistance to HER2 blockade in breast cancer

被引：34

作者：

Adam-Artigues, Anna ^{[1
]}

Arenas, Enrique J. ^{[2
,3
]}

Martinez-Sabadell, Alex ^{[2
]}

Braso-Maristany, Fara ^{[4
,5
]}

Cervera, Raimundo ^{[1
]}

Tormo, Eduardo ^{[1
,3
]}

Hernando, Cristina ^{[1
,6
]}

Teresa Martinez, Maria ^{[1
,6
]}

Carbonell-Asins, Juan ^{[1
]}

Simon, Soraya ^{[6
]}

Poveda, Jesus ^{[6
]}

Moragon, Santiago ^{[6
]}

Zazo, Sandra ^{[7
]}

Martinez, Debora ^{[4
,5
]}

Rovira, Ana ^{[3
,8
,9
]}

Burgues, Octavio ^{[1
,3
,10
]}

Rojo, Federico ^{[3
,7
]}

Albanell, Joan ^{[3
,8
,9
,11
]}

Bermejo, Begona ^{[1
,3
,6
]}

Lluch, Ana ^{[1
,3
,6
,12
]}

Prat, Aleix ^{[4
,5
,13
]}

Arribas, Joaquin ^{[2
,3
,9
,14
,15
]}

Eroles, Pilar ^{[1
,3
,16
]}

Miguel Cejalvo, Juan ^{[1
,3
,6
]}

机构：

[1] INCLIVA Biomed Res Inst, Valencia 46010, Spain

[2] Vall dHebron Inst Oncol VHIO, Preclin Res Program, Barcelona 08035, Spain

[3] Ctr Biomed Network Res Canc CIBERONC, Madrid 28019, Spain

[4] August Pi & Sunyer Biomed Res Inst IDIBAPS, Barcelona 08036, Spain

[5] Hosp Clin Barcelona, Dept Med Oncol, Barcelona 08036, Spain

[6] Hosp Clin Univ Valencia, Dept Med Oncol, Valencia 46010, Spain

[7] IIS Fdn Jimenez Diaz, Dept Pathol, Madrid 28040, Spain

[8] Hosp del Mar, Dept Med Oncol, Barcelona 08003, Spain

[9] IMIM Hosp del Mar Med Res Inst, Canc Res Program, Barcelona 08003, Spain

[10] Hosp Clin Univ Valencia, Dept Pathol, Valencia 46010, Spain

[11] Pompeu Fabra Univ UPF, Barcelona 08002, Spain

[12] Univ Valencia, Dept Med, Valencia 46010, Spain

[13] SOLTI Breast Canc Res Grp, Barcelona 08008, Spain

[14] Univ Autonoma Barcelona, Dept Biochem & Mol Biol, Barcelona 08193, Spain

[15] Inst Catalana Recerca & Estudis Avancats ICREA, Barcelona 08010, Spain

[16] Univ Valencia, Dept Physiol, Valencia 46010, Spain

来源：

SCIENCE ADVANCES | 2022年 / 8卷 / 20期

关键词：

RECEPTOR TYROSINE KINASES; TO-MESENCHYMAL TRANSITION; AXL; ACTIVATION; CELLS; TRASTUZUMAB; INHIBITION; MECHANISM; EGFR; CHEMOTHERAPY;

D O I：

10.1126/sciadv.abk2746

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Anti-HER2 therapies have markedly improved prognosis of HER2-positive breast cancer. However, different mechanisms play a role in treatment resistance. Here, we identified AXL overexpression as an essential mechanism of trastuzumab resistance. AXL orchestrates epithelial-to-mesenchymal transition and heterodimerizes with HER2, leading to activation of PI3K/AKT and MAPK pathways in a ligand-independent manner. Genetic depletion and pharmacological inhibition of AXL restored trastuzumab response in vitro and in vivo. AXL inhibitor plus trastuzumab achieved complete regression in trastuzumab-resistant patient-derived xenograft models. Moreover, AXL expression in HER2-positive primary tumors was able to predict prognosis. Data from the PAMELA trial showed a change in AXL expression during neoadjuvant dual HER2 blockade, supporting its role in resistance. Therefore, our study highlights the importance of targeting AXL in combination with anti-HER2 drugs across HER2-amplified breast cancer patients with high AXL expression. Furthermore, it unveils the potential value of AXL as a druggable prognostic biomarker in HER2-positive breast cancer.

引用

页数：18

共 55 条

[1] Epithelial-Mesenchymal Transitions in development and disease: old views and new perspectives
Angela Nieto, M.
[J]. INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY, 2009, 53 (8-10) : 1541 - 1547
[2] AXL-Driven EMT State as a Targetable Conduit in Cancer
Antony, Jane
Huang, Ruby Yun-Ju
[J]. CANCER RESEARCH, 2017, 77 (14) : 3725 - 3732
[3] The GAS6-AXL signaling network is a mesenchymal (Mes) molecular subtype-specific therapeutic target for ovarian cancer
Antony, Jane
Tan, Tuan Zea
Kelly, Zoe
Low, Jeffrey
Choolani, Mahesh
Recchi, Chiara
Gabra, Hani
Thiery, Jean Paul
Huang, Ruby Yun-Ju
[J]. SCIENCE SIGNALING, 2016, 9 (448)
[4] Acquired cancer cell resistance to T cell bispecific antibodies and CAR T targeting HER2 through JAK2 down-modulation
Arenas, Enrique J.
Martinez-Sabadell, Alex
Rius Ruiz, Irene
Roman Alonso, Macarena
Escorihuela, Marta
Luque, Antonio
Fajardo, Carlos Alberto
Gros, Alena
Klein, Christian
Arribas, Joaquin
[J]. NATURE COMMUNICATIONS, 2021, 12 (01)
[5] AXL induces epithelial-to-mesenchymal transition and regulates the function of breast cancer stem cells
Asiedu, M. K.
Beauchamp-Perez, F. D.
Ingle, J. N.
Behrens, M. D.
Radisky, D. C.
Knutson, K. L.
[J]. ONCOGENE, 2014, 33 (10) : 1316 - 1324
[6] Cooperative Targeting of Immunotherapy-Resistant Melanoma and Lung Cancer by an AXL-Targeting Antibody-Drug Conjugate and Immune Checkpoint Blockade
Boshuizen, Julia
Pencheva, Nora
Krijgsman, Oscar
Altimari, Daniela D'Empaire
Castro, Patricia Garrido
de Bruijn, Beaunelle
Ligtenberg, Maarten A.
Gresnigt-Van den Heuvel, Elke
Vredevoogd, David W.
Song, Ji-Ying
Visser, Nils
Apriamashvili, Georgi
Janmaat, Maarten L.
Plantinga, Theo S.
Franken, Patrick
Houtkamp, Mischa
Lingnau, Andreas
Jure-Kunkel, Maria
Peeper, Daniel S.
[J]. CANCER RESEARCH, 2021, 81 (07) : 1775 - 1787
[7] Cooperative targeting of melanoma heterogeneity with an AXL antibody-drug conjugate and BRAF/MEK inhibitors
Boshuizen, Julia
Koopman, Louise A.
Krijgsman, Oscar
Shahrabi, Aida
Gresnigt-van den Heuvel, Elke
Ligtenberg, Maarten A.
Vredevoogd, David W.
Kemper, Kristel
Kuilman, Thomas
Song, Ji-Ying
Pencheva, Nora
Mortensen, Jens Thing
Foppen, Marnix Geukes
Rozeman, Elisa A.
Blank, Christian U.
Janmaat, Maarten L.
Satijn, David
Breij, Esther C. W.
Peeper, Daniel S.
Parren, Paul W. H. I.
[J]. NATURE MEDICINE, 2018, 24 (02) : 203 - +
[8] EMT in cancer
Brabletz, Thomas
Kalluri, Raghu
Angela Nieto, M.
Weinberg, Robert A.
[J]. NATURE REVIEWS CANCER, 2018, 18 (02) : 128 - +
[9] Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockade
Braso-Maristany, Fara
Griguolo, Gaia
Pascual, Tomas
Pare, Laia
Nuciforo, Paolo
Llombart-Cussac, Antonio
Bermejo, Begona
Oliveira, Mafalda
Morales, Serafin
Martinez, Noelia
Vidal, Maria
Adamo, Barbara
Martinez, Olga
Pernas, Sonia
Lopez, Rafael
Munoz, Montserrat
Chic, Nuria
Galvan, Patricia
Garau, Isabel
Manso, Luis
Alarcon, Jesus
Martinez, Eduardo
Gregorio, Sara
Gomis, Roger R.
Villagrasa, Patricia
Cortes, Javier
Ciruelos, Eva
Prat, Aleix
[J]. NATURE COMMUNICATIONS, 2020, 11 (01)
[10] An Epithelial-Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance
Byers, Lauren Averett
Diao, Lixia
Wang, Jing
Saintigny, Pierre
Girard, Luc
Peyton, Michael
Shen, Li
Fan, Youhong
Giri, Uma
Tumula, Praveen K.
Nilsson, Monique B.
Gudikote, Jayanthi
Tran, Hai
Cardnell, Robert J. G.
Bearss, David J.
Warner, Steven L.
Foulks, Jason M.
Kanner, Steven B.
Gandhi, Varsha
Krett, Nancy
Rosen, Steven T.
Kim, Edward S.
Herbst, Roy S.
Blumenschein, George R.
Lee, J. Jack
Lippman, Scott M.
Ang, K. Kian
Mills, Gordon B.
Hong, Waun K.
Weinstein, John N.
Wistuba, Ignacio I.
Coombes, Kevin R.
Minna, John D.
Heymach, John V.
[J]. CLINICAL CANCER RESEARCH, 2013, 19 (01) : 279 - 290

← 1 2 3 4 5 6 →